Concepedia

Publication | Open Access

Conjugating Prussian Blue Nanoparticles Onto antigen-specific T Cells As a Combined Nanoimmunotherapy

61

Citations

15

References

2016

Year

Abstract

This study highlights the potential of our CTL:PBNPs nanoimmunotherapy as a novel therapeutic for treating virus-associated malignancies such as EBV+ cancers.

References

YearCitations

Page 1